Universal-Beteiligungs- und Servicegesellschaft
RIGL icon

Universal-Beteiligungs- und Servicegesellschaft’s Rigel Pharmaceuticals RIGL Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.16M Hold
55,200
– – ﹤0.01% 1280
2026
Q1 		$1.49M Hold
55,200
– – ﹤0.01% 1357
2025
Q4 		$2.36M Buy
+55,200
New +$2.08M ﹤0.01% 1205
2025
Q1 		– Sell
-40,200
Closed -$676K – 2001
2024
Q4 		$676K Buy
+40,200
New +$771K ﹤0.01% 960

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's RIGL Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft held its Rigel Pharmaceuticals (RIGL) position steady in Q2 2026 at 55,200 shares worth $2.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1280.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in RIGL in Q4 2024 and has held it in 4 quarters since. The position peaked at $2.36M in Q4 2025. 156 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 55,200 shares of Rigel Pharmaceuticals worth $2.16M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft left its Rigel Pharmaceuticals share count unchanged in Q2 2026.
  • Rigel Pharmaceuticals made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1280 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Rigel Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Rigel Pharmaceuticals position peaked at $2.36M in Q4 2025.
  • 156 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.